Skip to main content
Log in

Mass Balance Approaches for Estimating the Intestinal Absorption and Metabolism of Peptides and Analogues: Theoretical Development and Applications

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

A theoretical analysis for estimating the extent of intestinal peptide and peptide analogue absorption was developed on the basis of a mass balance approach that incorporates convection, permeability, and reaction. The macroscopic mass balance analysis (MMBA) was extended to include chemical and enzymatic degradation. A microscopic mass balance analysis, a numerical approach, was also developed and the results compared to the MMBA. The mass balance equations for the fraction of a drug absorbed and reacted in the tube were derived from the general steady state mass balance in a tube: dM/dZ = {[(2/R)(P w + k r)]CV L}/v z, where M is mass, z is the length of the tube, R is the tube radius, P w is the intestinal wall permeability, k r is the reaction rate constant, C is the concentration of drug in the volume element over which the mass balance is taken, V L is the volume of the tube, and v z is the axial velocity of drug. The theory was first applied to the oral absorption of two tripeptide analogues, cefaclor (CCL) and cefatrizine (CZN), which degrade and dimerize in the intestine. Simulations using the mass balance equations, the experimental absorption parameters, and the literature stability rate constants yielded a mean estimated extent of CCL (250-mg dose) and CZN (1000-mg dose) absorption of 89 and 51%, respectively, which was similar to the mean extent of absorption reported in humans (90 and 50%). It was proposed previously that 15% of the CCL dose spontaneously degraded systemically; however, our simulations suggest that significant CCL degradation occurs (8 to 17%) presystemically in the intestinal lumen. Insulin (M r = 5700), which is metabolized in the intestine primarily by α-chymotrypsin, was chosen for the second application of theory. The simulations show that the intestinal absorption of insulin is approximately 1% of the administered dose. Further, the extent of insulin oral absorption may not exceed 2% even if effective enzyme inhibitors are dosed concurrently since simulations show that insulin absorption is permeability limited. The steady-state macroscopic and microscopic simulation results were comparable and, for the antibiotics, were similar to published clinical results. Therefore, both approaches are useful for estimating the extent of oral peptide absorption and intestinal reaction from in vitro and in situ results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. V. H. L. Lee. Enzymatic barriers to peptide and protein absorption. CRC Crit. Rev. Ther. Drug Carrier Syst. 5:69–97 (1988).

    Google Scholar 

  2. M. H. Sleisenger and Y. S. Kim. Protein digestion and absorption. N. Engl. J. Med. 300:659–663 (1979).

    Google Scholar 

  3. D. M. Goldberg, R. Campbell, and A. D. Roy. Fate of trypsin and chymotrypsin in the human small intestine. GUT 10:477–483 (1969).

    Google Scholar 

  4. P. J. Sinko, G. D. Leesman, and G. L. Amidon. Predicting fraction dose absorbed in humans using a macroscopic mass balance approach. Pharm. Res. 8:979–988 (1991).

    Google Scholar 

  5. C. Y. Wen and L. T. Fan. Models for Flow Systems and Chemical Reactors, Marcel Dekker, New York, 1975.

    Google Scholar 

  6. G. L. Amidon, P. J. Sinko, and D. Fleisher. Estimating human oral fraction dose absorbed: A correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm. Res. 5:651–654 (1988).

    Google Scholar 

  7. S. S. Davis, J. G. Hardy, and J. W. Fara. Transit of pharmaceutical dosage forms through the small intestine. GUT 27:886–892 (1986).

    Google Scholar 

  8. G. D. Sides, T. R. Franson, K. A. DeSante, and H. R. Black. A comprehensive review of the clinical pharmacology and pharmacokinetics of cefaclor. Clin. Ther. 11 Suppl A (US):5–17 (1988).

    Google Scholar 

  9. D. A. Spyker, B. L. Thomas, M. A. Sande, and W. K. Bolton. Pharmacokinetics of cefaclor and cephalexin: Dosage nomograms for impaired renal function. Antimicrob. Agents Chemother. 21:278–281 (1982).

    Google Scholar 

  10. R. H. Barbhaiya, U. A. Shukla, C. R. Gleason, W. C. Shyu, R. B. Wilber, and K.A. Pittman. Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration. Antimicrob. Agents Chemother. 34:1204–1209 (1990).

    Google Scholar 

  11. E. Nakashima, A. Tsuji, M. Nakamura, and T. Yamana. Physiochemical properties of amphoteric β-lactam antibiotics. IV. First-and second-order degradations of cefaclor and cefatrizine in aqueous solution and kinetic interpretation of the intestinal absorption and degradation of the concentrated antibiotics. Chem. Pharm. Bull. 33:2098–2106 (1985).

    Google Scholar 

  12. M. Pfeffer, R. C. Gaver, and J. Ximenez. Human intravenous pharmacokinetics and absolute oral bioavailability of cefatrizine. Antimicrob. Agents Chemother. 24:915–920 (1983).

    Google Scholar 

  13. M. D. Donovan, G. L. Flynn, and G. L. Amidon. Absorption of polyethylene glycols 600 through 2000: The molecular weight dependence of gastrointestinal absorption. Pharm. Res. 7:863–868 (1990).

    Google Scholar 

  14. R. J. Schilling and A. K. Mitra. Degradation of insulin by trypsin and alpha-chymotrypsin. Pharm. Res. 8:721–727 (1991).

    Google Scholar 

  15. R. J. Schilling and A. K. Mitra. Intestinal mucosal transport of insulin. Int. J. Pharm. 62:53–64 (1990).

    Google Scholar 

  16. H. Rinderknecht, M. R. Nagaraja, and N. F. Adham. Enteropeptidase levels in duodenal juice of normal subjects and patients with gastrointestinal disease. Am. J. Digest. Dis. 23:327–331 (1978).

    Google Scholar 

  17. P. J. Sinko and G. L. Amidon. Characterization of the oral absorption of β-lactam antibiotics. I. Cephalosporins: Determination of intrinsic membrane absorption parameters in the rat intestine in situ. Pharm. Res. 5:645–650 (1988).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sinko, P.J., Leesman, G.D. & Amidon, G.L. Mass Balance Approaches for Estimating the Intestinal Absorption and Metabolism of Peptides and Analogues: Theoretical Development and Applications. Pharm Res 10, 271–275 (1993). https://doi.org/10.1023/A:1018999130076

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018999130076

Navigation